Author:
Cross N C P,Daley G Q,Green A R,Hughes T P,Jamieson C,Manley P,Mughal T,Perrotti D,Radich J,Skoda R,Soverini S,Vainchenker W,Verstovsek S,Villeval J-L,Goldman J M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference168 articles.
1. Dameshek W . Some speculations on the myeloproliferative syndromes. (Editorial). Blood 1951; 6: 372–375.
2. Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2007; 22: 14–22.
3. Fialkow PJ, Gartler SM, Yoshida A . Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 1967; 58: 1468–1471.
4. Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA . Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 1981; 58: 158–163.
5. Raskind WH, Farraris AM, Najfeld V, Jacobson RJ, Moohr JW, Fialkow PJ et al. Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia. Leukemia 1993; 7: 1163–1167.